ScienceDex / Researcher record
Janetka, James W
- Protexase Therapeutics, Inc. (no department on record)
From the FY2018 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
- Early Career
NIH Funding · FY2018
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2018 | $299,980 | 1 | #28,993 |
| 2019 | $299,972 | 1 | #30,551 |
| 2021 | $1,227,604 | 2 | #7,137 |
| 2022 | $1,973,243 | 3 | #3,713 |
| 2023 | $2,798,597 | 4 | #2,093 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2018 · selected1 record
- FY20191 record
- FY20212 records
- FY20223 records
- FY20234 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2018 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2018 award records by amount
NIH award records listing Janetka, James W as a PI. Multi-PI records show the full award amount for context.
- 1R43CA224832-01A1R43Contact PITargeting Hepatocyte Growth Factor Processing and Activation in Lung Cancer$300Kaward amount
Award organization
Organizations that administered FY2018 awards listing Janetka, James W as a PI.
FY2018 award administered by Protexase Therapeutics, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2018First NIH AwardProtexase Therapeutics, Inc.
- 2019$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #7137
- 2022$2M Cumulative Funding
- 2022Entered Top 25% NationallyRanked #3713
- 2023$5M Cumulative Funding